The Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Novartis’s Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis... Subscribe to Read More..
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |